| Literature DB >> 34800003 |
Hamed Nosrati1,2, Farzad Seidi1, Ali Hosseinmirzaei2, Navid Mousazadeh2, Ali Mohammadi2, Mohammadreza Ghaffarlou3, Hossein Danafar2, João Conde4,5, Ali Sharafi2.
Abstract
An optimal radiosensitizer with improved tumor retention has an important effect on tumor radiation therapy. Herein, gold nanoparticles (Au NPs) and drug-containing, mPEG-conjugated CUR (mPEG-CUR), self-assembled NPs (mPEG-CUR@Au) are developed and evaluated as a drug carrier and radiosensitizer in a breast cancer mice model. As a result, cancer therapy efficacy is improved significantly by applying all-in-one NPs to achieve synchronous chemoradiotherapy, as evidenced by studies evaluating cell viability, proliferation, and ROS production. In vivo anticancer experiments show that the mPEG-CUR@Au system improves the radiation sensitivity of 4T1 mammary carcinoma and completely abrogates breast cancer.Entities:
Keywords: chemoradiation therapy; drug conjugates; gold nanoparticles; high-Z nanoparticles; radiosensitizers
Mesh:
Substances:
Year: 2021 PMID: 34800003 DOI: 10.1002/adhm.202102321
Source DB: PubMed Journal: Adv Healthc Mater ISSN: 2192-2640 Impact factor: 9.933